Clinical data | |
---|---|
Trade names | Phenergan, others[1] |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682284 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth, rectal, intravenous, intramuscular, topical |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 88% absorbed but after first-pass metabolism reduced to 25% absolute bioavailability[2] |
Protein binding | 93% |
Metabolism | Liver glucuronidation and sulfoxidation |
Elimination half-life | 10–19 hours[2][3] |
Excretion | Kidney and Bile duct |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.445 |
Chemical and physical data | |
Formula | C17H20N2S |
Molar mass | 284.42 g·mol−1 |
3D model (JSmol) | |
Chirality | Racemic mixture |
| |
| |
(verify) |
Promethazine, sold under the brand name Phenergan among others, is a first-generation antihistamine, sedative, and antiemetic used to treat allergies, insomnia, and nausea. It may also help with some symptoms associated with the common cold[4] and may also be used for sedating people who are agitated or anxious, an effect that has led to some recreational use (especially with codeine).[5][6][7] Promethazine is taken by mouth (oral), as a rectal suppository, or by injection into a muscle (IM).[4]
Common side effects of promethazine include confusion and sleepiness;[4] consumption of alcohol or other sedatives can make these symptoms worse.[4] It is unclear if use of promethazine during pregnancy or breastfeeding is safe for the fetus.[4][6] Use of promethazine is not recommended in those less than two years old, due to potentially negative effects on breathing.[4] Use of promethazine by injection into a vein is not recommended, due to potential skin damage.[4] Promethazine is in the phenothiazine family of medications.[4] It is also a strong anticholinergic, which produces its sedative effects. This also means high or toxic doses can act as a deliriant.[8]
Promethazine was made in the 1940s by a team of scientists from Rhône-Poulenc laboratories.[9] It was approved for medical use in the United States in 1951.[4] It is a generic medication and is available under many brand names globally.[1] In 2022, it was the 198th most commonly prescribed medication in the United States, with more than 2 million prescriptions.[10][11] In 2022, the combination with dextromethorphan was the 260th most commonly prescribed medication in the United States, with more than 1 million prescriptions.[10][12]
pmid10965395
was invoked but never defined (see the help page).lean
was invoked but never defined (see the help page).